XML 16 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Revenue:        
Total revenue, net $ 14,544 $ 15,425 $ 38,701 $ 46,641
Costs and operating expenses:        
Cost of product revenue 1,774 1,561 4,980 4,396
Research and development 52,358 37,054 146,296 86,646
Selling and marketing 13,088 10,573 40,965 30,750
General and administrative 16,022 12,235 46,717 46,054
Total costs and operating expenses 83,242 61,423 238,958 167,846
Loss from operations (68,698) (45,998) (200,257) (121,205)
Other income (expense):        
Interest income 3,729 5,653 11,012 15,611
Interest expense (3,002) (3,224) (9,003) (10,471)
Change in fair value of derivative liabilities (1,447) 7,076 (3,066) (1,103)
Loss on extinguishment of debt       (27,950)
Gain on sale of property and equipment     29  
Total other income (expense), net (720) 9,505 (1,028) (23,913)
Net loss $ (69,418) $ (36,493) $ (201,285) $ (145,118)
Net loss per share, basic (in dollars per share) $ (0.38) $ (0.22) $ (1.15) $ (0.94)
Weighted average common shares outstanding, basic (in shares) 183,919,808 166,992,735 175,356,729 154,990,112
Net loss per share, diluted (in dollars per share) $ (0.38) $ (0.22) $ (1.15) $ (0.94)
Weighted average common shares outstanding, diluted (in shares) 183,919,808 166,992,735 175,356,729 154,990,112
Product revenue, net        
Revenue:        
Total revenue, net $ 14,544 $ 15,347 $ 38,573 $ 46,441
Collaboration revenue        
Revenue:        
Total revenue, net   $ 78 $ 128 $ 200